The Pfizer/BioNTech Corona virus jab got the green light for children aged five to 11 in Europe today, clearing the way for the vaccination in a cohort where the virus is rapidly spreading.<br />'' <br />'' The European Medicines Agency (EMA) said that a panel of experts recommended granting an extension of indication for the COVID-19 vaccine Comirnaty to include use in children aged five to 11, using the jab's brand name.<br />'' <br />'' The vaccine is already cleared for use in people aged 12 and over in the 27-nation EU. Pfizer's jab is has so far only been approved in a small number of countries for children aged five to 11 years in countries including the United States, Israel and Canada.<br />'' <br />'' In the Netherlands, where the EMA is based, authorities said earlier this week that the largest increase in cases was among children up to the age of 12 years.<br />'' <br />'' The regulator has so far approved four vaccines for use in the EU: Pfizer and Moderna, which use messenger RNA technology and AstraZeneca and Johnson & Johnson, which use viral vector technology.<br />''